首页 > 最新文献

Journal of Current Ophthalmology最新文献

英文 中文
Off-Label Uses of Ranibizumab and Aflibercept for Age-Related Macular Degeneration in Turkey. 雷尼单抗和阿非利塞普在土耳其治疗老年性黄斑变性的超说明书应用
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/joco.joco_323_22
Mevlut Yilmaz, Mehmet Citirik, Hanife Rahmanlar, Ali Alkan, Hakki Gursoz

Purpose: To evaluate the clinical and demographic aspects of off-label drug use applications for age-related macular degeneration (AMD) in Turkey.

Methods: Applications for off-label drug use in the treatment of AMD to the Turkish Medicines and Medical Devices Agency (TITCK) in 2018 were retrospectively analyzed. Demographic characteristics, requested drugs, previous treatment regimens, and reasons for applications were evaluated.

Results: The mean age of the patients (n = 209) was 64.9 ± 15.7 years, of which 48.8% were male and 51.2% were female. Ranibizumab (n = 113) comprised 54.1% and aflibercept (n = 96) 45.9% of off-label use applications. No application was made for bevacizumab. The most frequent reasons for application were switchback (49.3%), nonreimbursement of indicated drugs in cases under 50 years of age (24.4%), and failure to complete the loading dose (14.4%).

Conclusions: Ranibizumab was the most requested off-label drug for AMD. There was no application for off-label bevacizumab since its use does not require approval from TITCK. In Turkey, new rules were established for the reimbursement of intravitreal drugs for AMD in 2019. Three doses of intravitreal bevacizumab were required initially for aflibercept and ranibizumab to be covered for reimbursement. There is not enough data in the English literature regarding the off-label use of ranibizumab and aflibercept for AMD. This study provides information about drug regulations and the off-label treatment options preferred by physicians for AMD in Turkey.

目的:评估土耳其年龄相关性黄斑变性(AMD)的超说明书用药申请的临床和人口统计学方面。方法:回顾性分析2018年向土耳其药品和医疗器械管理局(TITCK)提交的治疗AMD的超说明书用药申请。评估了患者的人口统计学特征、要求的药物、既往治疗方案和申请的原因。结果:209例患者平均年龄64.9±15.7岁,其中男性48.8%,女性51.2%。Ranibizumab (n = 113)和afliberept (n = 96)分别占超说明书用药的54.1%和45.9%。未申请贝伐单抗。最常见的申请原因是切换(49.3%),50岁以下患者的适应症药物未报销(24.4%),以及未能完成加载剂量(14.4%)。结论:雷尼单抗是AMD最需要的说明书外药物。由于贝伐单抗的使用不需要获得tick的批准,因此没有说明书外用药申请。在土耳其,2019年制定了针对AMD的玻璃体内药物报销的新规则。阿非利塞普和雷尼单抗最初需要三剂量的玻璃体内贝伐单抗来报销。在英文文献中,没有足够的数据表明雷尼单抗和阿非利西普在标签外用于AMD。本研究提供了有关药物法规的信息,以及土耳其医生对AMD首选的标签外治疗方案。
{"title":"Off-Label Uses of Ranibizumab and Aflibercept for Age-Related Macular Degeneration in Turkey.","authors":"Mevlut Yilmaz,&nbsp;Mehmet Citirik,&nbsp;Hanife Rahmanlar,&nbsp;Ali Alkan,&nbsp;Hakki Gursoz","doi":"10.4103/joco.joco_323_22","DOIUrl":"https://doi.org/10.4103/joco.joco_323_22","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the clinical and demographic aspects of off-label drug use applications for age-related macular degeneration (AMD) in Turkey.</p><p><strong>Methods: </strong>Applications for off-label drug use in the treatment of AMD to the Turkish Medicines and Medical Devices Agency (TITCK) in 2018 were retrospectively analyzed. Demographic characteristics, requested drugs, previous treatment regimens, and reasons for applications were evaluated.</p><p><strong>Results: </strong>The mean age of the patients (<i>n</i> = 209) was 64.9 ± 15.7 years, of which 48.8% were male and 51.2% were female. Ranibizumab (<i>n</i> = 113) comprised 54.1% and aflibercept (<i>n</i> = 96) 45.9% of off-label use applications. No application was made for bevacizumab. The most frequent reasons for application were switchback (49.3%), nonreimbursement of indicated drugs in cases under 50 years of age (24.4%), and failure to complete the loading dose (14.4%).</p><p><strong>Conclusions: </strong>Ranibizumab was the most requested off-label drug for AMD. There was no application for off-label bevacizumab since its use does not require approval from TITCK. In Turkey, new rules were established for the reimbursement of intravitreal drugs for AMD in 2019. Three doses of intravitreal bevacizumab were required initially for aflibercept and ranibizumab to be covered for reimbursement. There is not enough data in the English literature regarding the off-label use of ranibizumab and aflibercept for AMD. This study provides information about drug regulations and the off-label treatment options preferred by physicians for AMD in Turkey.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/1b/JCO-35-61.PMC10481980.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10180028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tessier Number 9 Craniofacial Cleft Associated with Goldenhar Syndrome and Its Surgical Management: A Report of a Rare Case. Tessier 9号颅面裂合并Goldenhar综合征及其外科治疗:一例罕见病例报告。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/joco.joco_153_22
Abbas Bagheri, Mohadeseh Feizi, Mehdi Tavakoli

Purpose: To report surgical repair of a rare case of Tessier number 9 craniofacial cleft.

Methods: Case report.

Results: Tessier number 9 craniofacial cleft is the rarest cleft anomaly. This article reports a congenital eyelid coloboma in a 21-year-old woman that involved the lateral third of the left upper eyelid and extended to the lateral canthus, consistent with number 9 craniofacial cleft Tessier classification. The additional findings included a fibrotic band between the globe and the remnant of the upper lid, which caused a small-angle exotropia. There were also skin appendages in the preauricular area and the inner surface of the nasal columella consistent with Goldenhar syndrome. The eyelid coloboma was repaired by releasing the adhesions and using a composite graft of the hard palate to repair the posterior lamella. The anterior lamella was repaired by creating a skin advancement flap. The esthetic and functional outcomes were acceptable in the 2-year postoperative follow-up period.

Conclusion: The composite hard palate graft can be used to repair posterior lamella defect in the case of Tessier number 9 craniofacial cleft.

目的:报道一例罕见的Tessier 9号颅面裂的手术修复。方法:病例报告。结果:Tessier 9号颅面裂是最罕见的腭裂畸形。本文报告一例21岁女性先天性眼睑缺损,累及左上眼睑外侧三分之一,并延伸至外眦,符合9号颅面裂Tessier分类。其他发现包括球和上眼睑残余之间的纤维化带,导致小角度外斜视。耳前区和鼻小柱内表面也有皮肤附属物,符合Goldenhar综合征。通过解除粘连和使用硬腭复合移植物修复后板修复眼睑缺损。通过创建皮肤推进皮瓣修复前板。术后2年随访,美观和功能结果均可接受。结论:复合硬腭移植修复Tessier 9号颅面裂后板缺损是可行的。
{"title":"Tessier Number 9 Craniofacial Cleft Associated with Goldenhar Syndrome and Its Surgical Management: A Report of a Rare Case.","authors":"Abbas Bagheri,&nbsp;Mohadeseh Feizi,&nbsp;Mehdi Tavakoli","doi":"10.4103/joco.joco_153_22","DOIUrl":"https://doi.org/10.4103/joco.joco_153_22","url":null,"abstract":"<p><strong>Purpose: </strong>To report surgical repair of a rare case of Tessier number 9 craniofacial cleft.</p><p><strong>Methods: </strong>Case report.</p><p><strong>Results: </strong>Tessier number 9 craniofacial cleft is the rarest cleft anomaly. This article reports a congenital eyelid coloboma in a 21-year-old woman that involved the lateral third of the left upper eyelid and extended to the lateral canthus, consistent with number 9 craniofacial cleft Tessier classification. The additional findings included a fibrotic band between the globe and the remnant of the upper lid, which caused a small-angle exotropia. There were also skin appendages in the preauricular area and the inner surface of the nasal columella consistent with Goldenhar syndrome. The eyelid coloboma was repaired by releasing the adhesions and using a composite graft of the hard palate to repair the posterior lamella. The anterior lamella was repaired by creating a skin advancement flap. The esthetic and functional outcomes were acceptable in the 2-year postoperative follow-up period.</p><p><strong>Conclusion: </strong>The composite hard palate graft can be used to repair posterior lamella defect in the case of Tessier number 9 craniofacial cleft.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9b/52/JCO-35-93.PMC10481972.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10187185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Post-Coronavirus Disease 2019 Infection on the Retinal Microvasculature. 2019冠状病毒病后感染对视网膜微血管的影响
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/joco.joco_273_22
Nermien Salah El-Dien Mohammed El-Haddad, Elham Abd El-Wahed, Adel Abd El-Wahab, Sawssan Shalaby, Mona Mohammad Aly Farag, Nesma Sied Mohammed, Shrief Shawky

Purpose: To evaluate the short-term microvasculature changes of the macula and optic disc following coronavirus disease 2019 (COVID-19).

Methods: This study included 150 eyes (50 eyes of healthy controls and 100 eyes of patients) during the 1st month following COVID-19 recovery, as evidenced by two negative polymerase chain reactions. A complete ophthalmic examination and optical coherence tomography angiography were performed to detect the deep and superficial macular vessel density (VD). In addition, the VD of the optic disc was evaluated.

Results: Deep VD (DVD) showed a statistically significant decrease in post-COVID-19 patients, particularly those with severe COVID-19. This reduction occurred in the whole image, parafoveal, and perifoveal VD (P = 0.002, P = 0.002, and P < 0.001, respectively). Concerning the superficial VD (SVD), only the superior hemisphere of the whole image density was statistically significantly reduced (P = 0.037). There was no statistically significant difference in foveal VD (both deep and superficial vessel) among the study groups (P = 0.148 and P = 0.322, respectively). Regarding the foveal avascular zone (FAZ), there was no statistically significant among groups (P = 0.548). Regarding the optic disc, the whole image VD and redial peripapillary capillary VD demonstrated a highly significant decrease, particularly in cases of severe COVID-19. Conversely, inside disc VD showed a nonsignificant change among the study groups.

Conclusions: According to the findings of the current study, retinal microvasculature was affected in the 1st month following recovery from COVID-19. DVD was significantly reduced more than SVD. In addition, peripapillary VD decreased, whereas the FAZ was unaffected.

目的:评价冠状病毒病2019 (COVID-19)后黄斑和视盘的短期微血管变化。方法:本研究纳入150只眼睛(健康对照50只,患者100只),在COVID-19恢复后的第一个月内,有两次阴性聚合酶链反应。通过完整的眼科检查和光学相干断层血管造影检测黄斑深浅血管密度(VD)。此外,还对视盘VD进行了评估。结果:深度VD (DVD)在COVID-19后患者中呈显著下降趋势,尤其是重症患者。这种减少发生在整个图像、中央凹旁和中央凹周围VD (P = 0.002、P = 0.002和P < 0.001)。浅表VD (SVD)仅上半球全像密度降低,差异有统计学意义(P = 0.037)。各研究组中央凹VD(深浅血管)差异无统计学意义(P = 0.148、P = 0.322)。中央凹无血管区(FAZ)组间差异无统计学意义(P = 0.548)。对于视盘,整个图像VD和桡动脉乳头周围毛细血管VD显示出非常显著的下降,特别是在COVID-19严重的情况下。相反,在研究组中,盘内VD的变化不显著。结论:根据本研究结果,视网膜微血管在COVID-19康复后1个月内受到影响。DVD比SVD明显降低。此外,乳头周围VD减少,而FAZ未受影响。
{"title":"The Effect of Post-Coronavirus Disease 2019 Infection on the Retinal Microvasculature.","authors":"Nermien Salah El-Dien Mohammed El-Haddad,&nbsp;Elham Abd El-Wahed,&nbsp;Adel Abd El-Wahab,&nbsp;Sawssan Shalaby,&nbsp;Mona Mohammad Aly Farag,&nbsp;Nesma Sied Mohammed,&nbsp;Shrief Shawky","doi":"10.4103/joco.joco_273_22","DOIUrl":"https://doi.org/10.4103/joco.joco_273_22","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the short-term microvasculature changes of the macula and optic disc following coronavirus disease 2019 (COVID-19).</p><p><strong>Methods: </strong>This study included 150 eyes (50 eyes of healthy controls and 100 eyes of patients) during the 1<sup>st</sup> month following COVID-19 recovery, as evidenced by two negative polymerase chain reactions. A complete ophthalmic examination and optical coherence tomography angiography were performed to detect the deep and superficial macular vessel density (VD). In addition, the VD of the optic disc was evaluated.</p><p><strong>Results: </strong>Deep VD (DVD) showed a statistically significant decrease in post-COVID-19 patients, particularly those with severe COVID-19. This reduction occurred in the whole image, parafoveal, and perifoveal VD (<i>P</i> = 0.002, <i>P</i> = 0.002, and <i>P</i> < 0.001, respectively). Concerning the superficial VD (SVD), only the superior hemisphere of the whole image density was statistically significantly reduced (<i>P</i> = 0.037). There was no statistically significant difference in foveal VD (both deep and superficial vessel) among the study groups (<i>P</i> = 0.148 and <i>P</i> = 0.322, respectively). Regarding the foveal avascular zone (FAZ), there was no statistically significant among groups (<i>P</i> = 0.548). Regarding the optic disc, the whole image VD and redial peripapillary capillary VD demonstrated a highly significant decrease, particularly in cases of severe COVID-19. Conversely, inside disc VD showed a nonsignificant change among the study groups.</p><p><strong>Conclusions: </strong>According to the findings of the current study, retinal microvasculature was affected in the 1<sup>st</sup> month following recovery from COVID-19. DVD was significantly reduced more than SVD. In addition, peripapillary VD decreased, whereas the FAZ was unaffected.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/97/a3/JCO-35-50.PMC10481977.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10189113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Cataract Surgery-Assisted Selective Laser Trabeculoplasty: A Pilot Study. 白内障手术辅助选择性激光小梁成形术的有效性和安全性:一项初步研究。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/joco.joco_23_23
Dmitrii S Maltsev, Alexei N Kulikov, Alina A Kazak, Maria A Burnasheva, Alexander A Vasiliev

Purpose: To evaluate the intraocular pressure (IOP)-lowering effect and safety of selective laser trabeculoplasty (SLT) with same-day cataract surgery which we named cataract surgery-assisted selective laser trabeculoplasty (CAST) compared to conventional SLT and cataract surgery as standalone procedures.

Methods: Patients with primary open-angle glaucoma and cataract were included in this prospective interventional study. All patients received either a CAST procedure, standard SLT, or standard cataract surgery. IOP was assessed at baseline and at months 1, 2, 3, and 6. Topical IOP-lowering medication was canceled during the follow-up if necessary.

Results: Twenty-nine, twenty-seven, and thirty eyes received the CAST procedure, SLT, and standard cataract surgery, respectively. There was no statistically significant difference in age, male-to-female ratio, or baseline IOP between groups (P > 0.05). The mean IOP reduction at 6 months after the CAST procedure, SLT, and standard cataract surgery was -7.3 ± 3.8 mmHg, -3.8 ± 3.7 mmHg, and -0.7 ± 3.7 mmHg, respectively (P < 0.001). Eleven out of 29 (37.9%) and 5 out of 27 (18.5%) eyes achieved 30% reduction of IOP after the CAST procedure and SLT, respectively. No eyes achieved 30% reduction of IOP at the end of the follow-up in cataract surgery group. The median number of IOP-lowering medications cancelled after the CAST procedure was 1.0 (range, 0-3). No antiglaucoma medication was cancelled after SLT or cataract surgery. No adverse events were registered in patients who received the CAST procedure.

Conclusion: At 6-month follow-up, the CAST procedure had a significantly greater IOP-lowering effect and reduction of topical antiglaucoma medication than SLT or cataract surgery alone.

目的:评价选择性激光小梁成形术(SLT)联合当日白内障手术(我们称之为白内障手术辅助选择性激光小梁成形术(CAST))与传统的选择性激光小梁成形术和单独的白内障手术相比降低眼压(IOP)的效果和安全性。方法:对原发性开角型青光眼合并白内障患者进行前瞻性介入研究。所有患者均接受CAST手术、标准SLT或标准白内障手术。在基线和第1、2、3和6个月时评估IOP。如有必要,在随访期间取消局部降低眼压的药物。结果:分别有29眼、27眼和30眼接受了CAST、SLT和标准白内障手术。两组患者年龄、男女比、基线IOP差异无统计学意义(P > 0.05)。CAST手术、SLT和标准白内障手术后6个月的平均IOP降低分别为-7.3±3.8 mmHg、-3.8±3.7 mmHg和-0.7±3.7 mmHg (P < 0.001)。29只眼中有11只(37.9%)和27只眼中有5只(18.5%)分别在CAST手术和SLT手术后IOP降低了30%。随访结束时,白内障手术组没有眼的IOP降低30%。CAST手术后取消的降血压药物中位数为1.0(范围0-3)。SLT或白内障手术后没有取消抗青光眼药物。在接受CAST手术的患者中没有记录到不良事件。结论:在6个月的随访中,与单纯的SLT或白内障手术相比,CAST手术具有明显更大的降低眼压的效果和减少局部抗青光眼药物的使用。
{"title":"Efficacy and Safety of Cataract Surgery-Assisted Selective Laser Trabeculoplasty: A Pilot Study.","authors":"Dmitrii S Maltsev,&nbsp;Alexei N Kulikov,&nbsp;Alina A Kazak,&nbsp;Maria A Burnasheva,&nbsp;Alexander A Vasiliev","doi":"10.4103/joco.joco_23_23","DOIUrl":"https://doi.org/10.4103/joco.joco_23_23","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the intraocular pressure (IOP)-lowering effect and safety of selective laser trabeculoplasty (SLT) with same-day cataract surgery which we named cataract surgery-assisted selective laser trabeculoplasty (CAST) compared to conventional SLT and cataract surgery as standalone procedures.</p><p><strong>Methods: </strong>Patients with primary open-angle glaucoma and cataract were included in this prospective interventional study. All patients received either a CAST procedure, standard SLT, or standard cataract surgery. IOP was assessed at baseline and at months 1, 2, 3, and 6. Topical IOP-lowering medication was canceled during the follow-up if necessary.</p><p><strong>Results: </strong>Twenty-nine, twenty-seven, and thirty eyes received the CAST procedure, SLT, and standard cataract surgery, respectively. There was no statistically significant difference in age, male-to-female ratio, or baseline IOP between groups (<i>P</i> > 0.05). The mean IOP reduction at 6 months after the CAST procedure, SLT, and standard cataract surgery was -7.3 ± 3.8 mmHg, -3.8 ± 3.7 mmHg, and -0.7 ± 3.7 mmHg, respectively (<i>P</i> < 0.001). Eleven out of 29 (37.9%) and 5 out of 27 (18.5%) eyes achieved 30% reduction of IOP after the CAST procedure and SLT, respectively. No eyes achieved 30% reduction of IOP at the end of the follow-up in cataract surgery group. The median number of IOP-lowering medications cancelled after the CAST procedure was 1.0 (range, 0-3). No antiglaucoma medication was cancelled after SLT or cataract surgery. No adverse events were registered in patients who received the CAST procedure.</p><p><strong>Conclusion: </strong>At 6-month follow-up, the CAST procedure had a significantly greater IOP-lowering effect and reduction of topical antiglaucoma medication than SLT or cataract surgery alone.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/69/be/JCO-35-23.PMC10481979.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10189117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Letter to Editor: Unilateral Acute Central Serous Chorioretinopathy with Inactivated Coronavirus Disease 2019 Vaccination - A Case Report and Review of Literature. 回复编辑:单侧急性中枢性浆液性脉络膜视网膜病变合并灭活冠状病毒病2019疫苗1例报告及文献复习
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/joco.joco_111_23
Mojtaba Abrishami, Seyedeh Maryam Hosseini, Nasser Shoeibi, Hamid Reza Heidarzadeh
{"title":"Reply to Letter to Editor: Unilateral Acute Central Serous Chorioretinopathy with Inactivated Coronavirus Disease 2019 Vaccination - A Case Report and Review of Literature.","authors":"Mojtaba Abrishami,&nbsp;Seyedeh Maryam Hosseini,&nbsp;Nasser Shoeibi,&nbsp;Hamid Reza Heidarzadeh","doi":"10.4103/joco.joco_111_23","DOIUrl":"https://doi.org/10.4103/joco.joco_111_23","url":null,"abstract":"","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/a4/JCO-35-104.PMC10481985.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10180025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of Ocular Trauma in the Elderly: A Population-Based Study. 老年人眼外伤的流行病学:一项基于人群的研究。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/joco.joco_53_23
Alireza Hashemi, Mehdi Khabazkhoob, Ahmad Mehri, Abbasali Yekta, Abolghasem Mortazavi, Hassan Hashemi

Purpose: To determine the prevalence of different types of ocular trauma and their relationship with some factors in the elderly population.

Methods: The present population-based cross-sectional study was conducted on the elderly population aged 60 years and above in Tehran, Iran, using multi-stage stratified random cluster sampling in 2019. After selecting the samples and their participation in the study, demographic information and history of ocular trauma were obtained through an interview. Psychological evaluation was performed using the Goldberg's 28-question General Health Questionnaire. All study participants underwent optometric and ophthalmological examinations.

Results: Three thousand three hundred and ten people participated in the study (response rate: 87.3%). Of these, 1912 individuals (57.8%) were female and the mean age of individuals was 68.25 ± 6.55 (from 60 to 97) years. 7.46% (95% confidence interval [CI]: 6.51-8.41) of the study participants reported a history of ocular trauma. Blunt and chemical traumas were the most and the least common types of ocular trauma, respectively (5.72% and 0.16%). 3.93% of cases visited an ophthalmologist for ocular trauma, 1.67% reported a history of hospitalization, and 1.47% underwent surgery. The prevalence of visual impairment in individuals with a history of ocular trauma was 12.53%. Visual impairment was more prevalent in people with a history of ocular trauma than those without a history of ocular trauma (P < 0.05). History of ocular trauma was only significantly related to low education level (odds ratio = 0.63, 95% CI = 0.40-0.99). Participants with a history of ocular trauma had more anxiety and higher mean psychological distress score than those without a history of ocular trauma (P = 0.035).

Conclusions: The development of preventive programs against the occurrence of ocular trauma can play an important role in reducing the psychological damage of affected patients while reducing visual disorders. These interventions should be especially considered in groups with a lower education level.

目的:了解老年人不同类型眼外伤的发生率及其与相关因素的关系。方法:采用多阶段分层随机整群抽样方法,于2019年对伊朗德黑兰市60岁及以上老年人口进行基于人群的横断面研究。在选择样本并参与研究后,通过访谈获得人口统计学信息和眼外伤史。采用戈德堡28题一般健康问卷进行心理评估。所有研究参与者都接受了验光和眼科检查。结果:共有3310人参与研究,应答率为87.3%。其中雌性1912只(57.8%),平均年龄为68.25±6.55岁(60 ~ 97)岁。7.46%(95%可信区间[CI]: 6.51-8.41)的研究参与者报告有眼部外伤史。钝性和化学性损伤分别占5.72%和0.16%,是最常见的眼外伤类型。3.93%的患者就诊于眼科,1.67%的患者有住院史,1.47%的患者接受过眼科手术。有眼外伤史的人群视力损害发生率为12.53%。有眼外伤史者视力损害发生率高于无眼外伤史者(P < 0.05)。眼外伤史仅与教育程度低相关(优势比= 0.63,95% CI = 0.40-0.99)。有眼外伤史的受试者焦虑程度和平均心理困扰评分高于无眼外伤史的受试者(P = 0.035)。结论:制定预防眼外伤的方案,对减轻患者的心理损害,减少视力障碍具有重要作用。这些干预措施尤其应在教育水平较低的群体中加以考虑。
{"title":"Epidemiology of Ocular Trauma in the Elderly: A Population-Based Study.","authors":"Alireza Hashemi,&nbsp;Mehdi Khabazkhoob,&nbsp;Ahmad Mehri,&nbsp;Abbasali Yekta,&nbsp;Abolghasem Mortazavi,&nbsp;Hassan Hashemi","doi":"10.4103/joco.joco_53_23","DOIUrl":"https://doi.org/10.4103/joco.joco_53_23","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the prevalence of different types of ocular trauma and their relationship with some factors in the elderly population.</p><p><strong>Methods: </strong>The present population-based cross-sectional study was conducted on the elderly population aged 60 years and above in Tehran, Iran, using multi-stage stratified random cluster sampling in 2019. After selecting the samples and their participation in the study, demographic information and history of ocular trauma were obtained through an interview. Psychological evaluation was performed using the Goldberg's 28-question General Health Questionnaire. All study participants underwent optometric and ophthalmological examinations.</p><p><strong>Results: </strong>Three thousand three hundred and ten people participated in the study (response rate: 87.3%). Of these, 1912 individuals (57.8%) were female and the mean age of individuals was 68.25 ± 6.55 (from 60 to 97) years. 7.46% (95% confidence interval [CI]: 6.51-8.41) of the study participants reported a history of ocular trauma. Blunt and chemical traumas were the most and the least common types of ocular trauma, respectively (5.72% and 0.16%). 3.93% of cases visited an ophthalmologist for ocular trauma, 1.67% reported a history of hospitalization, and 1.47% underwent surgery. The prevalence of visual impairment in individuals with a history of ocular trauma was 12.53%. Visual impairment was more prevalent in people with a history of ocular trauma than those without a history of ocular trauma (<i>P</i> < 0.05). History of ocular trauma was only significantly related to low education level (odds ratio = 0.63, 95% CI = 0.40-0.99). Participants with a history of ocular trauma had more anxiety and higher mean psychological distress score than those without a history of ocular trauma (<i>P</i> = 0.035).</p><p><strong>Conclusions: </strong>The development of preventive programs against the occurrence of ocular trauma can play an important role in reducing the psychological damage of affected patients while reducing visual disorders. These interventions should be especially considered in groups with a lower education level.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/a0/JCO-35-79.PMC10481976.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10187188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Iris-Claw Intraocular Lens in Pediatric Ectopia Lentis: A Literature Review. 虹膜-爪形人工晶状体治疗儿童晶状体异位的疗效和安全性:文献综述。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/joco.joco_249_22
Dian Estu Yulia, Diajeng Ayesha Soeharto
Purpose: To review current evidence regarding the use of iris-claw intraocular lens (IOL) in terms of its efficacy and safety in the population of pediatric ectopia lentis. Methods: A comprehensive literature search of six electronic databases (PubMed-NCBI, Medline-OVID, Embase, Cochrane, Scopus, and Wiley) and secondary search through reference lists was conducted using keywords selected a priori. All primary studies on the use of iris-claw in pediatric ectopia lentis that evaluated visual acuity (VA), complications, and endothelial cell density (ECD) were included and critically appraised using the Newcastle–Ottawa Scale. Results: Ten studies were eligible for inclusion with an overall sample size of 168 eyes of children with ectopia lentis, and the majority of studies evaluated anterior iris-claw IOL. All studies reported improvement in postoperative VA. The most commonly reported complication across studies was IOL decentration. All studies reported decreasing ECD, and this was observed in both anterior and retropupillary iris-claw IOL. Conclusion: Current evidence shows that iris-claw IOL is effective in terms of improving VA in pediatric ectopia lentis. Due to the lack of long-term evidence of its safety in children, one must remain cautious regarding potential endothelial cell loss. Further high-quality, interventional, long-term studies are needed.
目的:回顾目前关于虹膜爪形人工晶状体(IOL)在儿童晶状体异位人群中的有效性和安全性的证据。方法:对PubMed-NCBI、Medline-OVID、Embase、Cochrane、Scopus、Wiley等6个电子数据库进行综合文献检索,并采用先验选择的关键词通过参考文献列表进行二次检索。所有使用虹膜钳法治疗儿童异位晶状体的初步研究都纳入了评估视力(VA)、并发症和内皮细胞密度(ECD)的研究,并使用纽卡斯尔-渥太华量表进行了严格评价。结果:10项研究符合纳入标准,总样本量为168只眼的儿童晶状体异位,大多数研究评估前虹膜-爪形人工晶状体。所有研究都报告了术后VA的改善。所有研究中最常见的并发症是IOL脱位。所有的研究都报告了ECD降低,这在瞳孔前和瞳孔后虹膜-爪式人工晶状体中都观察到了。结论:目前的证据表明,虹膜-爪形人工晶状体植入术对改善儿童异位晶状体的视功能是有效的。由于缺乏长期证据证明其在儿童中的安全性,因此必须对潜在的内皮细胞损失保持谨慎。需要进一步的高质量、干预性、长期研究。
{"title":"Efficacy and Safety of Iris-Claw Intraocular Lens in Pediatric Ectopia Lentis: A Literature Review.","authors":"Dian Estu Yulia,&nbsp;Diajeng Ayesha Soeharto","doi":"10.4103/joco.joco_249_22","DOIUrl":"https://doi.org/10.4103/joco.joco_249_22","url":null,"abstract":"Purpose: To review current evidence regarding the use of iris-claw intraocular lens (IOL) in terms of its efficacy and safety in the population of pediatric ectopia lentis. Methods: A comprehensive literature search of six electronic databases (PubMed-NCBI, Medline-OVID, Embase, Cochrane, Scopus, and Wiley) and secondary search through reference lists was conducted using keywords selected a priori. All primary studies on the use of iris-claw in pediatric ectopia lentis that evaluated visual acuity (VA), complications, and endothelial cell density (ECD) were included and critically appraised using the Newcastle–Ottawa Scale. Results: Ten studies were eligible for inclusion with an overall sample size of 168 eyes of children with ectopia lentis, and the majority of studies evaluated anterior iris-claw IOL. All studies reported improvement in postoperative VA. The most commonly reported complication across studies was IOL decentration. All studies reported decreasing ECD, and this was observed in both anterior and retropupillary iris-claw IOL. Conclusion: Current evidence shows that iris-claw IOL is effective in terms of improving VA in pediatric ectopia lentis. Due to the lack of long-term evidence of its safety in children, one must remain cautious regarding potential endothelial cell loss. Further high-quality, interventional, long-term studies are needed.","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/80/0b/JCO-35-1.PMC10481981.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10187190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vision-Related Quality of Life and Ocular Parameters in End-Stage Renal Disease Patients Undergoing Hemodialysis. 终末期肾脏疾病血液透析患者的视力相关生活质量和眼部参数。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/joco.joco_56_22
Sophia Moshegov, Ishith Seth, Olivia Wawryk, Sukhpal Singh Sandhu, Marc Lanteri, Paul N Baird, Srujana Sahebjada

Purpose: To evaluate the vision-related quality of life (VRQoL) of patients receiving hemodialysis through the assessment of the impact of vision impairment (IVI) questionnaire and ocular parameters, including best-corrected visual acuity (BCVA), intraocular pressure (IOP), and refraction as calculated by spherical equivalent (SE) of each eye.

Methods: Fifty-one patients with end-stage renal disease undergoing hemodialysis at a single center were recruited, and a total of 77 eyes were evaluated. BCVA, IOP, and SE were evaluated before and after hemodialysis (within 30 min).

Results: Of the 51 patients recruited, 13 (25%) were female, 37 (73%) were male, and one (2%) chose not to specify gender. The mean age was 61.85 ± 32 years. The mobility IVI score was correlated significantly with the presence of hypertension (P = 0.01), eye drop usage (P = 0.04), and gender (P = 0.04). Emotional IVI scores were correlated significantly with diabetes (P = 0.03) and hypertension (P < 0.01). IOP significantly correlated with the IVI overall score (P = 0.02), including the reading IVI subscale and the emotional IVI subscale. Several factors were associated with posthemodialysis ocular parameters, including predialysis ocular parameters, age, and hypertension (P < 0.05 for all).

Conclusions: IOP significantly correlated with VRQoL in hemodialysis patients. Demographic variables such as diabetes status, hypertension, eye drop usage, and gender also significantly correlated with subsections of the IVI questionnaire. This study investigated the relationship between ocular parameters and VRQoL in hemodialysis patients, and future longitudinal research is needed to further elucidate the mechanisms.

目的:通过评估视力损害(IVI)问卷和眼参数的影响,包括最佳矫正视力(BCVA)、眼内压(IOP)和每只眼球面等效(SE)计算的屈光度,评价血液透析患者的视力相关生活质量(VRQoL)。方法:在单一中心招募51例接受血液透析的终末期肾病患者,共评估77只眼睛。测定血液透析前后(30min内)BCVA、IOP、SE。结果:在招募的51例患者中,13例(25%)为女性,37例(73%)为男性,1例(2%)选择不指定性别。平均年龄61.85±32岁。活动性IVI评分与高血压存在(P = 0.01)、滴眼液使用(P = 0.04)、性别(P = 0.04)显著相关。情绪IVI评分与糖尿病(P = 0.03)、高血压(P < 0.01)有显著相关性。IOP与IVI总分显著相关(P = 0.02),包括阅读IVI分量表和情绪IVI分量表。几个因素与透析后眼参数相关,包括透析前眼参数、年龄和高血压(P < 0.05)。结论:血透患者IOP与VRQoL有显著相关性。人口统计变量,如糖尿病状况、高血压、眼药水使用和性别也与IVI问卷的各部分显著相关。本研究探讨了血透患者眼参数与VRQoL的关系,未来的纵向研究需要进一步阐明其机制。
{"title":"Vision-Related Quality of Life and Ocular Parameters in End-Stage Renal Disease Patients Undergoing Hemodialysis.","authors":"Sophia Moshegov,&nbsp;Ishith Seth,&nbsp;Olivia Wawryk,&nbsp;Sukhpal Singh Sandhu,&nbsp;Marc Lanteri,&nbsp;Paul N Baird,&nbsp;Srujana Sahebjada","doi":"10.4103/joco.joco_56_22","DOIUrl":"https://doi.org/10.4103/joco.joco_56_22","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the vision-related quality of life (VRQoL) of patients receiving hemodialysis through the assessment of the impact of vision impairment (IVI) questionnaire and ocular parameters, including best-corrected visual acuity (BCVA), intraocular pressure (IOP), and refraction as calculated by spherical equivalent (SE) of each eye.</p><p><strong>Methods: </strong>Fifty-one patients with end-stage renal disease undergoing hemodialysis at a single center were recruited, and a total of 77 eyes were evaluated. BCVA, IOP, and SE were evaluated before and after hemodialysis (within 30 min).</p><p><strong>Results: </strong>Of the 51 patients recruited, 13 (25%) were female, 37 (73%) were male, and one (2%) chose not to specify gender. The mean age was 61.85 ± 32 years. The mobility IVI score was correlated significantly with the presence of hypertension (<i>P</i> = 0.01), eye drop usage (<i>P</i> = 0.04), and gender (<i>P</i> = 0.04). Emotional IVI scores were correlated significantly with diabetes (<i>P</i> = 0.03) and hypertension (<i>P</i> < 0.01). IOP significantly correlated with the IVI overall score (<i>P</i> = 0.02), including the reading IVI subscale and the emotional IVI subscale. Several factors were associated with posthemodialysis ocular parameters, including predialysis ocular parameters, age, and hypertension (<i>P</i> < 0.05 for all).</p><p><strong>Conclusions: </strong>IOP significantly correlated with VRQoL in hemodialysis patients. Demographic variables such as diabetes status, hypertension, eye drop usage, and gender also significantly correlated with subsections of the IVI questionnaire. This study investigated the relationship between ocular parameters and VRQoL in hemodialysis patients, and future longitudinal research is needed to further elucidate the mechanisms.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b0/1e/JCO-35-66.PMC10481989.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10187187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unplanned Reoperation following Vitreoretinal Surgery. 玻璃体视网膜手术后意外再手术。
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/joco.joco_343_22
Ali Akbarzadeh, Amin Zand, Masoud Rahimi, Reza Mirshahi, Mohammad Mehdi Parvaresh, Khalil Ghasemi Falavarjani

Purpose: To evaluate the incidence of unplanned return to the operating room following vitreoretinal surgery and assess the reasons.

Methods: In this retrospective case series, medical records of all patients who underwent vitreoretinal surgery were reviewed to determine the incidence and reasons of early (<30 days postoperatively) and late (≥30 days postoperatively) unplanned reoperations after the surgery.

Results: A total of 488 eyes of 468 patients with a mean age of 55.84 ± 18.23 years were included. Fourteen percent (68/488) of eyes required one or more unplanned reoperation following their primary surgery. These include 3.9% (19/488) for the early and 10.0% (49/488) for the late reoperation. The most common primary reason for baseline surgery was rhegmatogenous retinal detachment (RRD) without proliferative vitreoretinopathy (PVR, 38.2%), followed by RD with PVR (23.5%), and tractional RD (TRD, 19.1%). Unplanned reoperations were most common in RD with PVR (19.3%), RRD without PVR (17.2%), and TRD (14.4%). Overall, the most common reasons of the first unplanned reoperation were repeated RD with PVR (27.9%), repeated RD (19.1%), and the presence of silicone oil (SO) in the anterior chamber (AC) (10.3%). For early unplanned reoperations, SO in AC, postoperative endophthalmitis, and persistent hyphema were the most common causes. Repeated RD with PVR was the most prevalent cause of late unplanned reoperations (34.7%). In the multivariate analysis, preoperative best-corrected visual acuity (BCVA) was significantly lower in eyes with unplanned reoperation than in eyes without (P = 0.011).

Conclusions: Unplanned reoperation following vitreoretinal surgery is not very common, and occurs mostly in the setting of PVR, RRD, and TRD. Lower preoperative BCVA may indicate an increased chance of future unplanned reoperation(s).

目的:探讨玻璃体视网膜手术后意外返回手术室的发生率及原因。方法:回顾性分析所有玻璃体视网膜手术患者的病历资料,确定早期病变的发生率及原因。结果:共纳入468例患者488只眼,平均年龄55.84±18.23岁。14%(68/488)的眼睛在初次手术后需要一次或多次计划外的再手术。其中早期为3.9%(19/488),晚期为10.0%(49/488)。基线手术最常见的主要原因是无增生性玻璃体视网膜病变的孔源性视网膜脱离(RRD) (PVR, 38.2%),其次是合并PVR的RD(23.5%)和牵引性RD (TRD, 19.1%)。计划外再手术在合并PVR的RD(19.3%)、无PVR的RRD(17.2%)和TRD(14.4%)中最为常见。总的来说,第一次计划外再手术的最常见原因是PVR的重复RD(27.9%),重复RD(19.1%)和前房(AC)存在硅油(SO)(10.3%)。对于早期非计划再手术,AC的SO,术后眼内炎和持续性前房积血是最常见的原因。重复RD合并PVR是晚期非计划再手术最常见的原因(34.7%)。在多因素分析中,术前最佳矫正视力(BCVA)在非计划再手术组明显低于未计划再手术组(P = 0.011)。结论:玻璃体视网膜手术后非计划再手术并不常见,多见于PVR、RRD和TRD。较低的术前BCVA可能表明未来非计划再手术的机会增加。
{"title":"Unplanned Reoperation following Vitreoretinal Surgery.","authors":"Ali Akbarzadeh,&nbsp;Amin Zand,&nbsp;Masoud Rahimi,&nbsp;Reza Mirshahi,&nbsp;Mohammad Mehdi Parvaresh,&nbsp;Khalil Ghasemi Falavarjani","doi":"10.4103/joco.joco_343_22","DOIUrl":"https://doi.org/10.4103/joco.joco_343_22","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the incidence of unplanned return to the operating room following vitreoretinal surgery and assess the reasons.</p><p><strong>Methods: </strong>In this retrospective case series, medical records of all patients who underwent vitreoretinal surgery were reviewed to determine the incidence and reasons of early (<30 days postoperatively) and late (≥30 days postoperatively) unplanned reoperations after the surgery.</p><p><strong>Results: </strong>A total of 488 eyes of 468 patients with a mean age of 55.84 ± 18.23 years were included. Fourteen percent (68/488) of eyes required one or more unplanned reoperation following their primary surgery. These include 3.9% (19/488) for the early and 10.0% (49/488) for the late reoperation. The most common primary reason for baseline surgery was rhegmatogenous retinal detachment (RRD) without proliferative vitreoretinopathy (PVR, 38.2%), followed by RD with PVR (23.5%), and tractional RD (TRD, 19.1%). Unplanned reoperations were most common in RD with PVR (19.3%), RRD without PVR (17.2%), and TRD (14.4%). Overall, the most common reasons of the first unplanned reoperation were repeated RD with PVR (27.9%), repeated RD (19.1%), and the presence of silicone oil (SO) in the anterior chamber (AC) (10.3%). For early unplanned reoperations, SO in AC, postoperative endophthalmitis, and persistent hyphema were the most common causes. Repeated RD with PVR was the most prevalent cause of late unplanned reoperations (34.7%). In the multivariate analysis, preoperative best-corrected visual acuity (BCVA) was significantly lower in eyes with unplanned reoperation than in eyes without (<i>P</i> = 0.011).</p><p><strong>Conclusions: </strong>Unplanned reoperation following vitreoretinal surgery is not very common, and occurs mostly in the setting of PVR, RRD, and TRD. Lower preoperative BCVA may indicate an increased chance of future unplanned reoperation(s).</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fd/1b/JCO-35-56.PMC10481975.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10180023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of a Missense Mutation in GJA8 Gene in an Iranian Family with Autosomal Dominant Congenital Cataract. 伊朗常染色体显性先天性白内障家族GJA8基因错义突变的鉴定
IF 1.5 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.4103/joco.joco_2_22
Mahla Asghari, Soheila Abedini, Melika Farshidianfar, Amir Tajbakhsh, Akbar Derakhshan, Alireza Pasdar

Purpose: To identify the causative mutations of autosomal dominant (AD) congenital cataracts in a large Iranian family.

Methods: The complete and accurate family history and clinical information of participants were collected. A total of 51 family members, including 22 affected and 29 unaffected individuals, were recruited in this study. We performed whole exome sequencing to reveal pathogenic mutation. We used amplification refractory mutation system polymerase chain reaction and Sanger sequencing techniques to confirm segregation in patients and also to rule it out in the healthy participants.

Results: A known missense mutation, c.827C>T (S276F), in GJA8 was identified. This mutation was confirmed in all patients. Neither all healthy family members nor 100 healthy individuals who served as controls from general population had this mutation.

Conclusion: The missense mutation c. 827C>T in the GJA8 gene is associated with AD congenital lamellar cataract with complete penetrance in a six-generation Iranian family.

目的:在伊朗一个大家族中鉴定常染色体显性(AD)先天性白内障的致病突变。方法:收集完整、准确的家族史和临床资料。这项研究共招募了51名家庭成员,其中包括22名受影响的人和29名未受影响的人。我们进行了全外显子组测序以揭示致病突变。我们使用扩增难治性突变系统聚合酶链反应和Sanger测序技术来确认患者的分离,并在健康参与者中排除这种分离。结果:在GJA8中发现了一个已知的错义突变c.827C>T (S276F)。所有患者都证实了这种突变。并非所有健康的家庭成员和100名健康个体作为普通人群的对照都有这种突变。结论:GJA8基因错义突变c. 827C>T与AD先天性板层性白内障有关,且在伊朗六代家族中具有完全外显性。
{"title":"Identification of a Missense Mutation in <i>GJA8</i> Gene in an Iranian Family with Autosomal Dominant Congenital Cataract.","authors":"Mahla Asghari,&nbsp;Soheila Abedini,&nbsp;Melika Farshidianfar,&nbsp;Amir Tajbakhsh,&nbsp;Akbar Derakhshan,&nbsp;Alireza Pasdar","doi":"10.4103/joco.joco_2_22","DOIUrl":"https://doi.org/10.4103/joco.joco_2_22","url":null,"abstract":"<p><strong>Purpose: </strong>To identify the causative mutations of autosomal dominant (AD) congenital cataracts in a large Iranian family.</p><p><strong>Methods: </strong>The complete and accurate family history and clinical information of participants were collected. A total of 51 family members, including 22 affected and 29 unaffected individuals, were recruited in this study. We performed whole exome sequencing to reveal pathogenic mutation. We used amplification refractory mutation system polymerase chain reaction and Sanger sequencing techniques to confirm segregation in patients and also to rule it out in the healthy participants.</p><p><strong>Results: </strong>A known missense mutation, c.827C>T (S276F), in <i>GJA8</i> was identified. This mutation was confirmed in all patients. Neither all healthy family members nor 100 healthy individuals who served as controls from general population had this mutation.</p><p><strong>Conclusion: </strong>The missense mutation c. 827C>T in the <i>GJA8</i> gene is associated with AD congenital lamellar cataract with complete penetrance in a six-generation Iranian family.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/92/fc/JCO-35-73.PMC10481974.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10180024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Current Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1